COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study
A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics
First rapid antigen test with performance data on children
Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
The company will receive up to $5 million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic
Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response
AI could hold the key to more targeted treatment, according to new research
VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
The BinaxNOW Self-Test will be sold in 2-count packs for an MSRP of $23.99, making it an affordable over-the-counter COVID-19 rapid test available in the U.S.
Watch this on-demand webinar to learn about the mechanisms behind cancer treatments such as CAR-T cells, checkpoint inhibitors or adoptive T cell therapy
Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies
